(1888PressRelease)
April 01, 2008 - Dr. Vatchara Phanchet, Chairman of Cryoviva (Thailand) today officially declared the company open. He said that the state-of-the-art laboratory is now ready for storage of Stem Cells from the Cord Blood.
Cryoviva is a joint venture between Indorama Group (Thailand) and R.J. Corp. (India) with licensed technology from world leaders Cryobank International USA.
Cryoviva has already completed the validation and approval following the standard operating procedures for Cryo-preservation of Cord Blood Stem Cells, which are prepared as per guideline of America Association of Blood Bank, Dr.Vatchara said.
Dr. Ratchnee O Charoen the Medical Director of Cryoviva (Thailand) said ,we want to be the most reliable company for Cord Blood Stem Cells cryo-preservation, with key focus on personalized services thus making Cryoviva the most trusted partner.
She also said Cryobanks Scientific and Medical Board of Advisors include some of the most illustrious names in the industry like Dr. Elaine Gluckman, who performed the first successful cord blood trans plant in the world.
It is part of Indorama’s corporate social responsibility to provide the infrastructure and support to Cryoviva. We are proud to be able to offer the best-in-class laboratory for Cord Blood Stem Cell cryo-preservation. Today Cord Blood Stem Cells are known to cure 75 life threatening diseases. The Umbilical Cord is truly a Lifeline for a Lifetime says Mrs. Suchitra Lohia Director of the Indorama Group.
More information, please contact :
KRIDSADAPORN CHUAYBAMRUNG - 081-448-7753
